Research Analysts’ upgrades for Thursday, August 24th:
Core Laboratories N.V. (NYSE:CLB) was upgraded by analysts at Credit Suisse Group to an outperform rating. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.
Chipotle Mexican Grill (NYSE:CMG) was upgraded by analysts at Stephens from an underweight rating to an equal weight rating.
Eaton Vance Corporation (NYSE:EV) was upgraded by analysts at J P Morgan Chase & Co from an underweight rating to a neutral rating.
Gentex Corporation (NASDAQ:GNTX) was upgraded by analysts at Robert W. Baird from a neutral rating to an outperform rating. They currently have $22.00 price target on the stock.
Intra-Cellular Therapies (NASDAQ:ITCI) was upgraded by analysts at JMP Securities from a market perform rating to an outperform rating. They currently have $24.00 target price on the stock.
Sse Plc (NASDAQ:SSEZY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $21.00 price target on the stock. According to Zacks, “SSE PLC is engaged in the generation, transmission, distribution, and supply of electricity in the United Kingdom and Ireland. The Company also stores and distributes natural gas and provides other energy-related services. It operates a telecommunications network that offers bandwidth and capacity to companies, public sector organizations, Internet service providers, and others. SSE PLC, formerly known as Scottish and Southern Energy plc, is based in Perth, the United Kingdom. “
Mast Therapeutics (NASDAQ:SVRA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $6.00 price target on the stock. According to Zacks, “Savara Inc. is a clinical-stage pharmaceutical company. It focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Savara Inc., formerly known as Mast Therapeutics, Inc., is based in Austin, United States. “
Del Taco Restaurants (NASDAQ:TACO) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $14.00 price target on the stock. According to Zacks, “Del Taco is the second largest Mexican-American QSR chain by units in the United States, serving more than three million guests each week. At Del Taco, menu items are made to order with fresh ingredients, including Cheddar cheese grated from 40-pound blocks, handmade pico de gallo salsa, lard-free beans slow-cooked from scratch, and marinated chicken grilled in the restaurant. The menu includes classic Mexican dishes such as tacos, burritos, quesadillas and nachos as well as American favorites including hamburgers, crinkle-cut fries and shakes. The company was founded on June 30, 2015 and is headquartered in Lake Forest, CA. “
Tempur Sealy International (NYSE:TPX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $69.00 target price on the stock. According to Zacks, “Tempur Sealy International, Inc. is involved in the development, manufacturing and marketing of bedding products primarily in North America and internationally. It provides mattresses, adjustable bases, pillows and other sleep and relaxation products. The company’s brand portfolio includes Tempur(R), Tempur-Pedic(R), Sealy(R), Sealy Posturepedic(R), Optimum(TM) and Stearns & Foster(R). Tempur Sealy International, Inc., formerly known as Tempur-Pedic International Inc., is headquartered in Lexington, Kentucky. “
Trivago N.V. ADS (NASDAQ:TRVG) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “trivago N.V. is a technology company. It provides internet-related services and products in the fields of hotels, lodging and metasearch. trivago N.V. is based in Duesseldorf, Germany. “
TDK Corp. (OTCMKTS:TTDKY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “TDK Corp. has a portfolio of technologies originally developed for its businesses involving electronic materials, components and devices, semiconductor, recording media and data storage devices. Its technical leadership includes materials research and development for dielectric, organic and semiconductor materials, process technologies for thick and thin film, metal, semiconductors and integration technologies. TDK technologies can be found in multimedia, video, television, personal computers, mobile communications, and semiconductors. (PRESS RELEASE) “
Vista Gold Corp. (NYSEMKT:VGZ) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $0.75 target price on the stock. According to Zacks, “Vista Gold Corp. is a mining company which produces gold from its Crofoot/Lewis mine in Nevada and explores for precious metals in the United Stattes, Canada, Mexico, Bolivia, Vanezuela and Ecuador. “
Valeo (OTCMKTS:VLEEY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $38.00 target price on the stock. According to Zacks, “Valeo SA designs, produces, and sells components, integrated systems, and modules for automobile industry. The Company has four business groups supplying products to the original equipment market and the aftermarket. The 4 Business Groups are: Powertrain Systems, Thermal Systems, Comfort and Driving Assistance Systems, and Visibility Systems. The Powertrain Systems offers electrical systems, transmission systems and hybrid and electric vehicle systems. The Thermal Systems products include climate control, compressors and front-end modules. The Comfort and Driving Assistance Systems products comprise driving assistance and access mechanisms. The Visibility Systems products are lighting systems, wiper Systems and wiper Motors. Valeo SA is headquartered in Paris, France. “
vTv Therapeutics (NASDAQ:VTVT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $5.25 target price on the stock. According to Zacks, “vTv Therapeutics Inc. is a biopharmaceutical company which is engaged in the discovery and development of orally administered small molecule drug candidates to fill unmet medical needs. Its drug candidate for the treatment of Alzheimers disease includes azeliragon TTP488, which is in Phase III clinical trials; type II diabetes drug candidates include Glucokinase Activator TTP399 and GLP-1r Agonist TTP273 which completed Phase I clinical trials; products for the prevention of muscle weakness and treatment of inflammatory disorders include HPP593, HPP737 and HPP971 which is in Phase1 clinical trials. The Company’s drug discovery platform consists of TTP Translational Technology. vTv Therapeutics Inc. is headquartered in High Point, North Carolina. “
Wentworth Resource Ord (NASDAQ:WENTF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Wentworth Resources Ltd. is an oil & gas company with: natural gas production; exploration and appraisal opportunities; large-scale gas monetisation initiatives primarily in the Rovuma Delta Basin of coastal southern Tanzania and northern Mozambique. Wentworth Resources Ltd. is headquartered in Calgary, Canada. “
